Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non–small cell lung cancer
- 1 December 2003
- journal article
- clinical trial
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 126 (6), 1943-1951
- https://doi.org/10.1016/j.jtcvs.2003.07.030
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- On the estimation of the binomial probability in multistage clinical trialsStatistics in Medicine, 2004
- The Noninvasive Staging of Non-small Cell Lung Cancer*Chest, 2003
- Noninvasive Staging of Non-small Cell Lung Cancer*Chest, 2003
- Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trialThe Lancet, 2002
- Metaanalyse zum Stellenwert der Positronen-Emissions-Tomographie mit F-18-Fluorodesoxyglukose (FDG-PET) bei Lungentumoren1 - Diskussionsbasis der deutschen Konsensus-Konferenz Onko-PET 2000 -Pneumologie, 2001
- Accuracy of Positron Emission Tomography for Diagnosis of Pulmonary Nodules and Mass LesionsJAMA, 2001
- Preoperative Staging of Non–Small-Cell Lung Cancer with Positron-Emission TomographyNew England Journal of Medicine, 2000
- Metastases from Non-Small Cell Lung Cancer: Mediastinal Staging in the 1990s—Meta-analytic Comparison Of PET and CTRadiology, 1999
- Optimal two-stage designs for phase II clinical trialsControlled Clinical Trials, 1989
- Confidence Intervals for a Binomial Parameter Following a Multistage Test With Application to MIL-STD 105D and Medical TrialsTechnometrics, 1983